| Company | Designation | Period |
|---|---|---|
| Glenmark Pharmaceuticals | Management Intern | May 2010 – Jun 2010 |
| Ranbaxy | Technical Intern | May 2007 – Jun 2007 |
| Glenmark Pharmaceuticals | Rotational Leadership Program | Jun 2014 – Jul 2015 |
| Glenmark Pharmaceuticals | Executive Assistant to Chairman & MD | Jun 2012 – Jan 2014 |
| MAN Impact Accelerator | Participating Founder | Jan 2018 – Jul 2018 |
| Glenmark Pharmaceuticals | Manager - Long Term Strategy for LATAM Markets | Jan 2014 – Jun 2014 |
| RED.Health (Formerly StanPlus) | Founder/CEO | Aug 2016 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Red.Health corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Prabhdeep Singh's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Red.Health's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)